Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SEELOS THERAPEUTICS, INC. | Financial_Report.xls |
| 10-K - 10-K - SEELOS THERAPEUTICS, INC. | v304648_10k.htm |
| EX-21 - EXHIBIT 21 - SEELOS THERAPEUTICS, INC. | v304648_ex21.htm |
| EX-2.1 - EXHIBIT 2.1 - SEELOS THERAPEUTICS, INC. | v304648_ex2-1.htm |
| EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC. | v304648_ex31-1.htm |
| EX-32.2 - EXHIBIT 32.2 - SEELOS THERAPEUTICS, INC. | v304648_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - SEELOS THERAPEUTICS, INC. | v304648_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC. | v304648_ex32-1.htm |
| EX-10.31 - EXHIBIT 10.31 - SEELOS THERAPEUTICS, INC. | v304648_ex10-31.htm |
| EX-23.2 - EXHIBIT 23.2 - SEELOS THERAPEUTICS, INC. | v304648_ex23-2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Apricus Biosciences, Inc. on Forms S-3 (Nos. 333-148060, 333-107137, 333-122114, 333-117717, 333-125565, 333-140110, 333-152591, 333-132611, 333-111894, 333-105509, 333-165958, 333-165960, 333-178592, 333-178832, 333-96813, 333-46967 and 333-91957) and Forms S-8 (Nos. 333-152284, 333-138598, 333-174392, 333-167365 and 333-93435) of our report dated March 13, 2012, on our audits of the consolidated financial statements as of December 31, 2011 and 2010 and for each of the years in the two-year period ended December 31, 2011, and the effectiveness of Apricus Biosciences, Inc. and Subsidiaries’ internal control over financial reporting as of December 31, 2011, which report is included in this Annual Report on Form 10-K. We also have audited the adjustments described in Note 1 that were applied to restate the 2009 consolidated financial statements for the 15 to 1 reverse stock split. In our opinion, such adjustments are appropriate and have been properly applied. We were not engaged to audit, review, or apply any procedures to the 2009 consolidated financial statements of Apricus Biosciences, Inc. and Subsidiaries other than with respect to the adjustments and, accordingly, we do not express an opinion or any other form of assurance on the 2009 consolidated financial statements taken as a whole.
/s/ EisnerAmper LLP
Edison, New Jersey
March 13, 2012